[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100397709":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":29,"locations":37,"responsibleParty":56,"collaborators":59,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":10,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":10,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"University of California, San Diego","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"No increased risk of hypoglycemia",null,"Infants born with no obvious risk factors for hypoglycemia in the neonatal period.",[13],"Device: Dexcom continuous glucose monitor",{"label":15,"type":10,"description":16,"interventionNames":17},"Increased risk of hypoglycemia","Infants considered at increased risk for hypoglycemia after birth including the following criteria:\n\n* Infant born to a diabetic mother\n* Very large for gestational age (VLGA) infant with weight \\>97%",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DEVICE","Dexcom continuous glucose monitor","Measurement of interstitial glucose",[15,9],[25],{"name":26,"affiliation":27,"role":28},"Jane Kim, MD","University of California San Diego\u002FRady Children's Hospital","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Valentina Stanley, BS","CONTACT","(858) 249-5985","vstanley@health.ucsd.edu",{"name":26,"role":32,"phone":36,"phoneExt":10,"email":10},"(858) 966-4032",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"UCSD Medical Center","RECRUITING","La Jolla","California","92037","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-117.2742,32.84727,{"lat":50,"lon":49},[53,55],{"name":31,"role":32,"phone":54,"phoneExt":10,"email":34},"858-966-4032",{"name":26,"role":32,"phone":54,"phoneExt":10,"email":10},{"type":28,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Dr Jane Kim","Professor of Pediatrics",[60],{"name":61,"class":62},"DexCom, Inc.","INDUSTRY","100397709","continuous-glucose-monitoring-in-infants-100397709",false,"NCT04458649","Continuous Glucose Monitoring in Infants","Inclusion Criteria:\n\n* Mother at least 18 years of age\n* Infants born either appropriate for gestational age (AGA) or large for gestational age (LGA)\n* Skin fold over superior gluteus area at least 1 inch in thickness as measured by skin calipers\n\nExclusion Criteria:\n\n* Infants born small for gestational age (SGA)\n* Infant birth weight \\\u003C2.5 kg\n* Infant BMI \\\u003C10th percentile on Olsen chart\n* Infants born \\\u003C38 weeks gestation\n* Infants with concern for intrauterine growth restriction (IUGR) and short femur length based on ultrasound\n* Mother is non-English speaking",true,"ALL","1 Hour","2 Hours",{"count":74,"type":75},200,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.",[79],"Neonatal Hypoglycemia","2024-07-01",{"date":82,"type":83},"2024-07-03","ACTUAL",{"date":85,"type":83},"2020-10-01",{"date":87,"type":75},"2024-12-31",{"name":5,"class":6},1]